Bcl-2 mediates induction of neural differentiation

Oncogene

Volumn 22, Issue 35, 2003, Pages 5515-5518

  Liang, Ye ^a   Mirnics, Zeljka Korade ^a   Yan, Chaohua ^a   Nylander, Karen D ^a   Schor, Nina Felice ^a,b  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b Division of Child Neurology   (United States)

Author keywords

Bcl 2; DNA microarray; Nerve growth factor; Neural differentiation; TrkA

Indexed keywords

CATHEPSIN H; CHROMOGRANIN B; DNA; FIBROBLAST GROWTH FACTOR; MEMBRANE PROTEIN; NERVE GROWTH FACTOR; NEUROMODULIN; PROTEIN BCL 2; SOMATOMEDIN BINDING PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRAIN; CONTROLLED STUDY; DNA MICROARRAY; GENE EXPRESSION; MOUSE; NERVE CELL; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ANIMALS; CELL DIFFERENTIATION; EMBRYONIC INDUCTION; NERVE GROWTH FACTOR; NEURAL CREST; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PC12 CELLS; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RECEPTOR, TRKA;

ANIMALIA;

EID: 0042836587     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206844     Document Type: Article

References (24)

1. Boilly B, Vercoutter-Edouart AS, Hondermarck H, Nurcombe V and Le Bourhis X. (2000). Cytokine Growth Factor Rev., 11, 295-302.
2. Bottner M, Krieglstein K and Unsicker K. (2000). J. Neurochem., 75, 2227-2240.
3. Cortazzo MH and Schor NF. (1996). Cancer Res., 56, 1199-1203.
4. Fujita A and Kurachi Y. (2000). Biochem. Biophys. Res. Commun., 269, 1-6.
5. Greene LA. (1978). J. Cell Biol., 78, 747-755.
6. Grellier P, De Galle B and Babajko S. (1998). Cancer Res., 58, 1670-1676.
7. Hamada S and Yagi T. (2001). Neurosci. Res., 41, 207-215.
8. Huttunen HJ, Kuja-Panula J and Rauvala H. (2002). J. Biol. Chem., 277, 38635-38646.
9. Joseph R, Dou D and Tsang W. (1995). Brain Res., 690, 92-98.
10. Joseph R, Tsang W, Dou D, Nelson K and Edvardsen K. (1996). Brain Res., 738, 32-38.
11. Kalaydjieva L, Gresham D, Gooding R, Heather L, Baas F, de Jonge R, Blechschmidt K, Angelicheva D, Chandler D, Worsley P, Rosenthal A, King RH and Thomas PK. (2000). Am. J. Hum. Genet., 67, 47-58.
12. Kane DJ, Sarafian TA, Anton R, Hahn H, Gralla EB, Valentine JS, Ord T and Bredesen DE. (1993). Science, 262, 1274-1277.
13. Liang Y, Nylander KD and Schor NF. (2002). Molec. Pharmacol., 61, 142-149.
14. Mani S, Shen Y, Schaefer J and Meiri KF. (2001). Mol. Cell. Neurosci., 17, 54-66.
15. Middleton G, Pinon LG, Wyatt S and Davies AM. (1998). J. Neurosci., 18, 3344-3350.
16. Oh YJ, Swarzenski BC and O'Malley KL. (1996). Neurosci. Lett., 202, 161-164.
17. Rong YP, Liu F, Zeng LC, Ma WJ, Wei DZ and Han ZG. (2002). Sheng Wu Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai), 34, 411-417.
18. Saragovi HU, Zheng WH, Maliartchouk S, DiGugliemo GM, Mawal YR, Kamen A, Woo SB, Cuello AC, Debeir T and Neet KE. (1998). J. Biol. Chem., 273, 34933-34940.
19. Schor NF, Rudin CM, Hartmann A-R, Thompson CB, Tyurina YY and Kagan VE. (2000). Oncogene, 19, 472-476.
20. Schwartz CS, Seyfried J, Evert BO, Klockgether T and Wullner U. (2002). NeuroReport, 13, 2439-2442.
21. Suzuki A and Tsutomi Y. (1998). Brain Res., 801, 59-66.
22. Vaudry D, Stork PJ, Lazarovici P and Eiden LE. (2002). Science, 296, 1648-1649.
23. Yan C, Liang Y, Nylander KD and Schor NF. (2002). Cancer Res., 62, 4867-4875.
24. Zhang KZ, Westberg JA Hölttä E and Anderson LC. (1996). Proc. Natl. Acad. Sci. USA, 93, 4504-4508.